Please login to the form below

CoStim Pharmaceuticals

This page shows the latest CoStim Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Novartis enters PD-1 race via CoStim acquisition

Expands presence in cancer immunotherapies. Novartis has reached a deal to acquire US company CoStim Pharmaceuticals, expanding its position in the hot topic of cancer immunotherapy. ... Boston, Massachusetts-based CoStim - which started operations in

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Director of Scientific Services, Medical Communications, Six fig...: Six figure salary

Senior Medical Writer, MedComms Agency: Salary TBC

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Principal Medical Writer: £48 - 58, 000 according to skills and experience benefits

Account Director or Senior Account Director: Salary TBC

Consultant: competitive salary

Account Manager– Medical Communications: (Negotiable - depending on experience)

Vice President: Competitive Salary Offered

Subscribe to our email news alerts

PMHub

Add my company

Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

How do companies prepare for reimbursement?: Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
Integrating electronic health records into clinical trials: How organisations are working to realise the research potential of EHRs...
Keeping up the fight against HIV and using the lessons to tackle other threats: Danny Buckland interviews Gilead’s Mike Elliott...